News
FDA taps biotech veteran George Tidmarsh to lead drug center
The Food and Drug Administration on Monday named George Tidmarsh, a longtime biotech executive who has a background in oncology and pediatrics, as its top drug regulator. Tidmarsh, who will be the director for the FDA’s Center for Drug Evaluation and Research,
Gardenia blue is the latest plant-based dye approved by the FDA as part of a push to phase out synthetic colors ...
Axios on MSN8h
Drugmaker refuses FDA request to pull gene therapyAn unusual public feud between the Food and Drug Administration and a maker of gene therapies for rare diseases could test ...
News Nation on MSN3d
FDA chief: HRT warning among ‘greatest mistakes of modern medicine’( NewsNation) — The head of the U.S. Food and Drug Administration signaled Thursday that he supports changing or removing the ...
Food and Drug Administration Commissioner Dr. Marty Makary joins 'Fox & Friends Weekend' to discuss the MAHA push as major ...
Axios on MSN3d
FDA panel backs menopausal hormone therapyAn Food and Drug Administration expert panel on Thursday endorsed removing the "black box" warning on hormone treatments for ...
MedPage Today on MSN4d
A 'Culture Change' Is Needed in Academic Medicine, FDA Commissioner SaysThe culture of academic medicine needs to change, FDA Commissioner Marty Makary, MD, MPH, said at an event sponsored by The ...
During a press conference on Monday, Food and Drug Administration Commissioner Marty Makary spoke about the agency's ...
Stocktwits on MSN3d
FDA Is Reportedly ‘Taking A Hard Look’ To Evaluate Whether Sarepta’s Gene Therapy Elevidys Should Remain On The MarketUS Food and Drug Administration Commissioner Marty Makary said he’s “taking a hard look” at whether Sarepta Therapeutics’ gene therapy, Elevidys, should remain on the market, following recent patient ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback